Do Not Use Pedicloryl (Dextromethorphan) in a 1-Year-Old Infant
Pedicloryl syrup containing dextromethorphan is contraindicated for children under 6 years of age according to the FDA-approved product labeling 1. This recommendation aligns with current pediatric guidelines that strongly advise against over-the-counter cough medications in young children due to lack of efficacy and potential for serious adverse events.
Why This Medication Should Not Be Used
The FDA drug label for Pedicloryl explicitly states: "Children under 6: Ask a doctor" 1, and the approved dosing begins only at 6 years of age (2 mL every 6 hours for children 6-12 years) 1. This is not simply a conservative recommendation—it reflects substantial safety concerns.
Current pediatric guidelines from CHEST and the American Academy of Pediatrics are unequivocal: Over-the-counter cough and cold medicines should not be prescribed for children with acute cough until they have been shown to make cough less severe or resolve sooner 2. The evidence shows these preparations, particularly those containing dextromethorphan, are associated with adverse events including reported deaths from toxicity in young children 2.
The Evidence Against Use in Young Children
Multiple lines of evidence support avoiding dextromethorphan in this age group:
Lack of efficacy: A systematic review found that OTC cough medications have little, if any, benefit in symptomatic control of acute cough in children 2. One pediatric study specifically in children aged 1-10 years with respiratory infections found no significant difference in cough frequency or severity with dextromethorphan compared to placebo 3.
Safety concerns: Accidental ingestions in children under 5 years commonly result in lethargy as the primary neurological manifestation 4. While most cases in that study did well with supportive care, the mean dose ingested was only 2.64 mg/kg 4—and toxicity guidelines recommend emergency department referral for ingestions exceeding 7.5 mg/kg 5.
Regulatory action: The FDA issued warnings against using OTC cough and cold medications in young children, leading manufacturers to voluntarily relabel products as "do not use in children under 4 years of age" 2. In 2018, FDA further restricted prescription opioid cough medicines to adults ≥18 years 2.
What to Recommend Instead
For a 1-year-old with cough:
Identify the underlying cause through clinical evaluation—chronic cough may signal serious respiratory or systemic illness requiring specific treatment 2
Consider honey (for children ≥12 months): Honey may offer more relief for cough symptoms than no treatment, diphenhydramine, or placebo 2. This is the only evidence-based symptomatic treatment for this age group.
Avoid all OTC cough medications: The balance of potential harm versus negligible benefit makes their use inappropriate 2
Treat the underlying etiology: Cough in children should be treated based on the specific cause, not symptomatically with antitussives 2
Critical Pitfall to Avoid
Do not attempt to calculate a "pediatric dose" based on adult dosing or body weight for dextromethorphan in this age group. Even though research has explored doses of 0.35-0.94 mg/kg in children aged 2-18 years 6, this does not establish safety or efficacy in 1-year-olds, and the FDA labeling explicitly excludes children under 6 years from approved use 1.